Skip to main content
. 2014 Jul 28;7:439–447. doi: 10.2147/JPR.S63028

Table 3.

Number of treatment-emergent adverse events (AEs)

Treatment-related, n (%) All causalities, n (%)
Patients with ≥1 AE 90 (87.4) 100 (97.1)
Patients with ≥1 serious AE 1 (1.0) 19 (18.4)
Patients with ≥1 severe AE 4 (3.9) 12 (11.7)
Discontinuations due to AE 13 (12.6) 16 (15.5)
Deaths 0 0